Literature DB >> 23138098

Alpha thalassaemia and extended alpha globin genes in Sri Lanka.

Sasikala Suresh1, Christopher Fisher, Helena Ayyub, Anuja Premawardhena, Angela Allen, Ashok Perera, Dayananda Bandara, Nancy Olivieri, David Weatherall.   

Abstract

The α-globin genes were studied in nine families with unexplained hypochromic anaemia and in 167 patients with HbE β thalassaemia in Sri Lanka. As well as the common deletion forms of α(+) thalassaemia three families from an ethnic minority were found to carry a novel form of α(0) thalassaemia, one family carried a previously reported form of α(0) thalassaemia, --(THAI), and five families had different forms of non-deletional thalassaemia. The patients with HbE β thalassaemia who had co-inherited α thalassaemia all showed an extremely mild phenotype and reduced levels of HbF and there was a highly significant paucity of α(+) thalassaemia in these patients compared with the normal population. Extended α gene arrangements, including ααα, αααα and ααααα, occurred at a low frequency and were commoner in the more severe phenotypes of HbE β thalassaemia. As well as emphasising the ameliorating effect of α thalassaemia on HbE β thalassaemia the finding of a novel form of α(0) thalassaemia in an ethnic minority, together with an unexpected diversity of forms of non-deletion α thalassaemia in Sri Lanka, further emphasises the critical importance of micro-mapping populations for determining the frequency of clinically important forms of the disease. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138098     DOI: 10.1016/j.bcmd.2012.10.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

Review 1.  Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates.

Authors:  Miroslav Dostalek; Thomayant Prueksaritanont; Robert F Kelley
Journal:  MAbs       Date:  2017-05-02       Impact factor: 5.857

Review 2.  α-Globin as a molecular target in the treatment of β-thalassemia.

Authors:  Sachith Mettananda; Richard J Gibbons; Douglas R Higgs
Journal:  Blood       Date:  2015-04-13       Impact factor: 22.113

3.  Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Authors:  Emma Jones; Sant-Rayn Pasricha; Angela Allen; Patricia Evans; Chris A Fisher; Katherine Wray; Anuja Premawardhena; Dyananda Bandara; Ashok Perera; Craig Webster; Pamela Sturges; Nancy F Olivieri; Timothy St Pierre; Andrew E Armitage; John B Porter; David J Weatherall; Hal Drakesmith
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

4.  Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.

Authors:  Zeshuai Deng; Fang Yang; Yao Bai; Lijun He; Qing Li; Yanrui Wu; Lan Luo; Hong Li; Limei Ma; Zhaoqing Yang; Yongshu He; Liwang Cui
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

5.  Prevalence and aetiologies of anaemia among first trimester pregnant women in Sri Lanka; the need for revisiting the current control strategies.

Authors:  Gayani Shashikala Amarasinghe; Thilini Chanchala Agampodi; Vasana Mendis; Krishanthi Malawanage; Chamila Kappagoda; Suneth Buddhika Agampodi
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-06       Impact factor: 3.105

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.